Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Original Paper
  • Published:

Association with Cdc2 and inhibition of Cdc2/Cyclin B1 kinase activity by the p53-regulated protein Gadd45

Oncogene volume 18, pages 2892–2900 (1999)Cite this article

Abstract

Recently Gadd45, a p53-regulated stress protein, has been implicated in the activation of a G2/M checkpoint after damage by UV radiation and alkylating agents. While inhibitory phosphorylation of Cdc2 and suppression of cyclin B1 levels are known to be involved in G2 delays after genotoxic stress, Gadd45 has now been found to directly inhibit the activity of Cdc2/Cyclin B1 complex, while it had no appreciable effect on Cdk2/Cyclin E activity even at very high levels of Gadd45. In contrast, p21Cip1/Waf1 is an universal cdk/cyclin inhibitor and inhibited both of the cyclin complexes tested here. Gadd45 was also able to physically interact with Cdc2, but not Cyclin B1. Addition of Gadd45 to immunoprecipitated Cdc2/Cyclin B1 in vitro led to a dissociation of this complex, and thus may represent a new checkpoint mechanism whereby Cdc2/Cyclin B1 can be inhibited. With the use of an antisense approach, reduced Gadd45 expression attenuated the suppression of Cdc2/Cyclin B1 activity in UV-irradiated human cells. Taken together, these results implicate Gadd45 in the control of G2/M cell cycle progression after certain stresses.

This is a preview of subscription content, access via your institution

Access options

Buy this article

  • Purchase on Springer Link
  • Instant access to full article PDF
Buy now

Prices may be subject to local taxes which are calculated during checkout

Figure 1
Figure 2
Figure 3
Figure 4
Figure 5

Similar content being viewed by others

References

  • Agarwal ML, Agarwal A, Taylor WR and Stark GR. . 1995 Proc. Natl. Acad. Sci. USA 92: 8493–8497.

  • Bernhard EJ, Maity A, Muschel RJ and McKenna WG. . 1995 Radiat. Environ. Biophys. 34: 79–83.

  • Carrier F, Smith ML, Bae I, Kilpatrick KE, Chen CY, Johnson KJ, Henner WD, Gilmer T, Kastan MB and Fornace Jr AJ. . 1994 J. Biol. Chem. 269: 32672–32677.

  • Cross SM, Sanchez CA, Morgan CA, Schimke MK, Ramel S, Idzerda RL, Raskind WH and Reid BJ. . 1995 Science 267: 1353–1356.

  • Dulic V, Stein GH, Far DF and Reed SI. . 1998 Mol. Cell. Biol. 18: 546–557.

  • Elledge SJ. . 1996 Science 274: 1664–1672.

  • Fan S, Smith ML, Rivet II DJ, Duba D, Zhan Q, Kohn KW, Fornace Jr AJ and O'Connor PM. . 1995 Cancer Res. 55: 1649–1654.

  • Fujii-Nakata T, Ishimi Y, Okuda A and Kikuchi A. . 1992 J. Biol. Chem. 267: 20980–20986.

  • Fukasawa K, Choi T, Kuriyama R, Rulong S and Vande Woude GF. . 1996 Science 271: 1744–1747.

  • Guillouf C, Rosselli F, Krishnaraju K, Moustacchi E, Hoffman B and Liebermann DA. . 1995 Oncogene 10: 2263–2270.

  • Hartwell LH and Kastan MB. . 1994 Science 266: 1821–1828.

  • Hermeking H, Lengauer C, Polyak K, He TC, Zhang L, Thiagalingam S, Kinzler K and Vogelstein B. . 1997 Molecular Cell 1: 3–11.

  • Kao GD, McKenna WG, Maity A, Blank K and Muschel RJ. . 1997 Cancer Res. 57: 753–758.

  • Kearsey JM, Coates PJ, Prescott AR, Warbrick E and Hall PA. . 1995 Oncogene 11: 1675–1683.

  • Khan SH and Wahl GM. . 1998 Cancer Res. 58: 396–401.

  • Kilpatrick KE, Carrier F, Smith ML, Chen CY, Lee AJ, Rusnak DW, Kastan MB, Fornace AJJ, Champion BR, Gilmer TM, et al. 1995 Hybridoma 14: 355–359.

  • Ko LJ and Prives C. . 1996 Genes Dev. 10: 1054–1072.

  • Lanni JS and Jacks T. . 1998 Mol. Cell. Biol. 18: 1055–1064.

  • Maity A, McKenna WG and Muschel RJ. . 1995 EMBO J. 14: 603–609.

  • Medema RH, Klompmaker R, Smits VA and Rijksen G. . 1998 Oncogene 16: 431–441.

  • O'Connor PM. . 1997 Cancer Surv 29: 151–182.

  • Papathanasiou MA, Kerr NC, Robbins JH, McBride OW, Alamo IJ, Barrett SF, Hickson ID and Fornace Jr AJ. . 1991 Mol. Cell. Biol. 11: 1009–1016.

  • Paulovich AG, Toczyski DP and Hartwell LH. . 1997 Cell 88: 315–321.

  • Powell SN, DeFrank JS, Connell P, Eogan M, Preffer F, Dombkowski D, Tang W and Friend S. . 1995 Cancer Res. 55: 1643–1648.

  • Rupp RA, Snider L and Weintraub H. . 1994 Genes Dev. 8: 1311–1323.

  • Smith ML, Chen I, Zhan Q, Bae I, Chen C, Gilmer T, Kastan MB, O'Connor PM and Fornace Jr AJ. . 1994 Science 266: 1376–1380.

  • Smith ML and Fornace Jr AJ. . 1996 Mutation Res. 340: 109–124.

  • Smith ML, Kontny HU, Zhan Q, Sreenath A, O'Connor PM and Fornace Jr AJ. . 1996 Oncogene 13: 2255–2263.

  • Stewart N, Hicks GG, Paraskevas F and Mowat M. . 1995 Oncogene 10: 109–115.

  • Thompson DA, Belinsky G, Chang THT, Jones DL, Schlegel R and Munger K. . 1997 Oncogene 15: 3025–3035.

  • Turner DL and Weintraub H. . 1994 Genes Dev. 8: 1434–1447.

  • Wang XW, Zhan Q, Coursen JD, Khan M, Kontny HU, O'Connor PM, Fornace Jr AJ and Harris CC. . 1997 Proc. Am. Assoc. Cancer Res. 38: 201.

  • Zhan Q, Lord KA, Alamo IJ, Hollander MC, Carrier F, Ron D, Kohn KW, Hoffman B, Liebermann DA and Fornace Jr, AJ. . 1994 Mol. Cell. Biol. 14: 2361–2371.

  • Zhan Q, El-Deiry W, Bae I, Alamo Jr I, Kastan MB, Vogelstein B and Fornace Jr AJ. . 1995 Int. J. Oncology 6: 937–946.

Download references

Author information

Author notes

  1. Qimin Zhan

    Present address: Pittsburgh Cancer Institute, University of Pittsburgh School of Medicine, Pittsburgh, Pennsylvania, USA

  2. France Carrier

    Present address: Department of Biochemistry and Molecular Biology, University of Maryland, Baltimore, 21201-1503, Maryland, USA

  3. Martin L Smith

    Present address: Indiana University Cancer Center, Indianapolis, IN 46202, USA

Authors and Affiliations

  1. Division of Basic Science, Laboratory of Biological Chemistry, National Cancer Institute, National Institutes of Health, Bethesda, 20892, Maryland, USA

    Qimin Zhan, Michael J Antinore, France Carrier, Martin L Smith & Albert J Fornace Jr

  2. Division of Basic Science, Laboratory of Human Carcinogenesis, National Cancer Institute, National Institutes of Health, Bethesda, 20892, Maryland, USA

    Xin Wei Wang & Curtis C Harris

Authors
  1. Qimin Zhan
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Michael J Antinore
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Xin Wei Wang
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. France Carrier
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Martin L Smith
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. Curtis C Harris
    View author publications

    You can also search for this author in PubMed Google Scholar

  7. Albert J Fornace Jr
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and permissions

About this article

Cite this article

Zhan, Q., Antinore, M., Wang, X. et al. Association with Cdc2 and inhibition of Cdc2/Cyclin B1 kinase activity by the p53-regulated protein Gadd45. Oncogene 18, 2892–2900 (1999). https://doi.org/10.1038/sj.onc.1202667

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/sj.onc.1202667

Keywords

This article is cited by

Search

Advanced search

Quick links